Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials.
Vanessa SelakRuth WebsterSandrine StepienChris BullenAnushka PatelSimon ThomBruce ArrollMichiel L BotsAlex BrownSue CrenglePrabhakaran DorairajC Raina ElleyDiederick E GrobbeeMatire HarwoodGraham S HillisTracey-Lea LabaBruce NealDavid PeirisNatasha RafterChristopher ReidAlice StantonAndrew TonkinTim UsherwoodAngela WadhamAnthony RodgersPublished in: Heart (British Cardiac Society) (2018)
Polypill-based therapy significantly improved the achievement of all three ESC targets for BP, LDL and antiplatelet therapy compared with usual care, particularly among those undertreated at baseline.
Keyphrases
- antiplatelet therapy
- clinical trial
- acute coronary syndrome
- percutaneous coronary intervention
- open label
- healthcare
- palliative care
- double blind
- phase ii
- study protocol
- phase iii
- affordable care act
- coronary artery disease
- stem cells
- placebo controlled
- pain management
- atrial fibrillation
- randomized controlled trial
- health insurance
- chronic pain
- smoking cessation